DCRI Pediatrician Contributes to Guidance on Pediatric Weight-Loss Surgery
The DCRI’s Sarah Armstrong, MD, served as the lead author for a policy statement and a co-author on a technical report advocating for more widespread use of bariatric and metabolic surgeries for ch
DCRI to Lead Pragmatic Study to Assess Effectiveness of Statins in Older Adults
A $90 million award expected from the National Institute of Aging and the National Heart, Lung, & Blood Institute will fund the largest pragmatic trial with placebo-controlled drug assignm
DCRI Receives Grant to Develop Measures for Pain in Infants and Young Children
Investigators will develop a core set of endpoints and measures to be used in clinical trials and spur development of new pain medications for young children.
Study Suggests Strokes May be Treated Differently than Heart Attacks
A recent study from DCRI researchers found that patients who have had strokes may receive different care than those who have had heart attacks, despite evidence that shows statins are effective for secondary prevention in both populations to prevent recurring ischemic events.
DCRI’s Piccini Weighs in on Catheter Ablation in Cardiology Today
Mixed results from the CABANA trial have led to debate about whether catheter ablation is an effective treatment option that provides benefit to patients with atrial fibrillation.
PTN Receives NIH Funding to Advance Down Syndrome Research
Research from DCRI investigators will help determine whether medications prescribed off-label to individuals with Down syndrome are safe and effective.
DCRI Contributes to FDA Guidance to Improve Medication Safety in Newborns
Research guidance recently issued by the FDA provides clarity regarding clinical trial study design, drug dosing, and analysis in studies of newborns.
DCRI-Co-sponsored Workshop Identifies Key Issues in E-cigarette Use in Youth
Recent media attention regarding the risks of vaping and e-cigarettes have led to many questions about the health impacts of using these products, particularly among young people. Findings from a recent workshop highlight why this issue is so complicated and what strategies may help to overcome the problem.
Differences in Patient Beliefs May Play Role in Women’s Underuse of Statins
Women are less likely than men to receive statins, and those who do receive statins are more likely to receive a prescription below recommended guidelines. DCRI fellow Michael Nanna, MD (pictured), examined patient data from the PALM (Patient and Provider Assessment of Lipid Management) Registry in an effort to ascertain reasons for these differences. He and his team found that women are offered statins at lower rates but refuse or discontinue statins at higher rates than men.